Journal of General Internal Medicine

, Volume 20, Issue 12, pp 1142–1145 | Cite as

The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans

  • Kristina Crothers
  • Tephany A. Griffith
  • Kathleen A. McGinnis
  • Maria C. Rodriguez-Barradas
  • David A. Leaf
  • Sharon Weissman
  • Cynthia L. Gibert
  • Adeel A. Butt
  • Amy C. Justice
Populations At Risk

Abstract

BACKGROUND: The impact of smoking on outcomes among those with HIV infection has not been determined in the era of highly active antiretroviral therapy (HAART).

STUDY OBJECTIVE: Determine the impact of smoking on morbidity and mortality in HIV-positive patients post-HAART.

DESIGN: Prospective observational study.

PARTICIPANTS: Eight hundred and sixty-seven HIV-positive veterans enrolled in the Veterans Aging Cohort 3 Site Study.

MEASUREMENTS: Clinical data were collected through patient questionnaire, International Classification of Diseases—9th edition codes, and standardized chart extraction, and laboratory and mortality data through the national VA database. Quality of life was assessed with the physical component summary (PCS) of the Short-Form 12.

RESULTS: Current smokers had increased respiratory symptoms, chronic obstructive pulmonary disease (COPD), and bacterial pneumonia. In analyses adjusted for age, race/ethnicity, CD4 cell count, HIV RNA level, hemoglobin, illegal drug and alcohol use, quality of life was substantially decreased (β=−3.3, 95% confidence interval [CI] −5.3 to −1.4) and mortality was significantly increased (hazard ratio 1.99, 95% CI 1.03 to 3.86) in current smokers compared with never smokers.

CONCLUSIONS: HIV-positive patients who currently smoke have increased mortality and decreased quality of life, as well as increased respiratory symptoms, COPD, and bacterial pneumonia. These findings suggest that smoking cessation should be emphasized for HIV-infected patients.

Key Words

HIV AIDS smoking mortality health-related quality of life 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003;362:847–52.PubMedCrossRefGoogle Scholar
  2. 2.
    Burns DN, Hillman D, Neaton JD, et al. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:374–83.PubMedGoogle Scholar
  3. 3.
    Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W Jr. Comorbidity and survival in HIV-infected men in the San Francisco Men’s Health Survey. Ann Epidemiol. 1996;6:420–30.PubMedCrossRefGoogle Scholar
  4. 4.
    Galai N, Park LP, Wesch J, Visscher B, Riddler S, Margolick JB. Effect of smoking on the clinical progression of HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:451–8.PubMedGoogle Scholar
  5. 5.
    Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis. 2000;31:808–12.PubMedCrossRefGoogle Scholar
  6. 6.
    Turner J, Page-Shafer K, Chin DP, et al. Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care STDS. 2001;15:615–24.PubMedCrossRefGoogle Scholar
  7. 7.
    Diaz PT, Wewers MD, Pacht E, Drake J, Nagaraja HN, Clanton TL. Respiratory symptoms among HIV-seropositive individuals. Chest. 2003;123:1977–82.PubMedCrossRefGoogle Scholar
  8. 8.
    Nieman RB, Fleming J, Coker RJ, Harris JR, Mitchell DM. The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals. AIDS. 1993;7:705–10.PubMedCrossRefGoogle Scholar
  9. 9.
    Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med. 1995;333:845–51.PubMedCrossRefGoogle Scholar
  10. 10.
    Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD. The association between cigarette smoking and selected HIV-related medical conditions. AIDS. 1996;10:1121–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Wallace JM, Hansen NI, Lavange L, et al. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 1997;155:72–80.PubMedGoogle Scholar
  12. 12.
    Palella FJ Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–60.PubMedCrossRefGoogle Scholar
  13. 13.
    Mocroft A, Brettle R, Kirk O, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16:1663–71.PubMedCrossRefGoogle Scholar
  14. 14.
    Smola S, Justice AC, Wagner J, Rabeneck L, Weissman S, Rodriguez-Barradas M. Veterans aging cohort three-site study (VACS 3): overview and description. J Clin Epidemiol. 2001;54(suppl 1):S61–76.PubMedCrossRefGoogle Scholar
  15. 15.
    Ware JEJ, Kosinski M, Keller SD. SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales. Boston, Mass: The Health Institute, New England Medical Center; 1995.Google Scholar
  16. 16.
    Ware J Jr., Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.PubMedCrossRefGoogle Scholar
  17. 17.
    McGinnis KA, Fine MJ, Sharma RK, et al. Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data. Am J Public Health. 2003;93:1728–33.PubMedCrossRefGoogle Scholar
  18. 18.
    Miguez-Burbano MJ, Burbano X, Ashkin D, et al. Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy. Addict Biol. 2003;8:39–43.PubMedCrossRefGoogle Scholar
  19. 19.
    Aberg JA, Gallant JE, Anderson J, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2004;39:609–29.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2005

Authors and Affiliations

  • Kristina Crothers
    • 1
  • Tephany A. Griffith
    • 2
  • Kathleen A. McGinnis
    • 3
  • Maria C. Rodriguez-Barradas
    • 4
  • David A. Leaf
    • 5
    • 6
  • Sharon Weissman
    • 7
  • Cynthia L. Gibert
    • 8
    • 9
  • Adeel A. Butt
    • 10
  • Amy C. Justice
    • 11
  1. 1.Pulmonary and Critical Care Medicine, Department of Internal MedicineYale University School of MedicineNew HavenUSA
  2. 2.General Internal Medicine, Department of Internal MedicineYale University School of MedicineNew HavenUSA
  3. 3.University Center for Social and Urban Research, University of Pittsburgh, and Center for Health Equity Research and PromotionVA Pittsburgh Healthcare SystemPittsburghUSA
  4. 4.Medical Service, Infectious Diseases, Michael E. DeBakey VA Medical Center, and Department of MedicineBaylor College of MedicineHoustonUSA
  5. 5.General Internal Medicine, Department of Internal MedicineUniversity of CaliforniaLos Angeles
  6. 6.Greater Los Angeles VA Medical CenterLos AngelesUSA
  7. 7.Department of Internal MedicineHospital of Saint RaphaelNew HavenUSA
  8. 8.Department of MedicineGeorge Washington UniversityUSA
  9. 9.Section of Infectious DiseasesVA Medical CenterUSA
  10. 10.Infectious Diseases, Department of Internal MedicineUniversity of Pittsburgh School of MedicinePittsburghUSA
  11. 11.General Internal Medicine, Department of Internal MedicineVA Connecticut Healthcare System, and Yale University School of MedicineNew HavenUSA

Personalised recommendations